We are looking for partnering opportunities on new assets in advanced research or preclinical development stages that could be useful for the treatment of dermatological diseases. Preferably, the assets should: - Target immuno-inflammatory pathways or be suitable for dermato-oncological or rare dermatological indications - Involve any therapeutic modality such as small molecules, biologics or advanced therapies - Demonstrate strong scientific rationale, including in vitro and in vivo evidences of efficacy, if available
- This call is addressed to scientists affiliated to start-ups, biotechs, universities, research centres, and pharmaceutical companies all over the world. - Scientists interested in participating are encouraged to submit their proposals through AlmirallShare.